PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK, Warwick Medical School, Coventry, UK and Coventry University, Coventry, UK timothy.robbins@nhs.net.\', \'Midlands Diving Chamber, Rugby, UK.\', \'University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK and Coventry University, Coventry, UK.\', \'University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.\', \'deputy chief executive officer and consultant cardiologist, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK and Warwick Medical School, Coventry, UK.\', \'University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK and Warwick Medical School, Coventry, UK.\', \'University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK, Warwick Medical School, Coventry, UK and Coventry University, Coventry, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7861/clinmed.2021-0462
?:hasPublicationType
?:journal
  • Clinical medicine (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34862223
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all